Pancreatic Neoplasms  >>  evofosfamide (IMGS-101)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
EMR200592-002, NCT01833546: A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer

Completed
1
20
Japan
Evofosfamide, Gemcitabine
Merck KGaA, Darmstadt, Germany, Threshold Pharmaceuticals
Solid Tumor, Pancreatic Cancer
08/15
01/16
EMR200592-006, NCT02047500: Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer

Checkmark ASCO 2016
May 2016 - May 2016: ASCO 2016
Terminated
1
19
US
TH-302, Nab-paclitaxel, Gemcitabine
Threshold Pharmaceuticals
Pancreatic Cancer
09/15
05/16

Download Options